TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, 'Titan Medical Inc.”) ('the 'Resulting Issuer” or the 'Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. ('Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the 'Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercialize and develop Conavi's Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.